We treated NKG2D-deficient (Klrk1−/−) and sufficient (Klrk1+/+) mice with DEN to induce liver damage and study the progression of HCC, the expression of NKG2D ligands, and the immune composition of the liver tissue. The gene discussed is KLRK1; the disease is hepatocellular carcinoma.